Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer

被引:122
作者
Chen, Z-Y [1 ]
Raghav, K. [2 ]
Lieu, C. H. [3 ]
Jiang, Z-Q [2 ]
Eng, C. [2 ]
Vauthey, J-N [4 ]
Chang, G. J. [4 ]
Qiao, W. [5 ]
Morris, J. [5 ]
Hong, D. [6 ]
Hoff, P. [7 ]
Tran, H. [8 ]
Menter, D. G. [2 ]
Heymach, J. [8 ]
Overman, M. [2 ]
Kopetz, S. [2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[3] Univ Colorado, Div Med Oncol, Aurora, CO USA
[4] Univ Texas Houston, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[5] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[6] Univ Texas Houston, MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[7] Univ Sao Paulo, Fac Med, Oncol Clin, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[8] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
angiogenesis; cytokine; growth factors; inflammation; metastatic colorectal cancer; neutrophil-lymphocyte ratio; survival; CHRONIC INFLAMMATION; COLON-CANCER; GENETIC INSTABILITY; POOR-PROGNOSIS; SOLID TUMORS; BIOMARKERS; BEVACIZUMAB; RESISTANCE; CARCINOMA; THERAPY;
D O I
10.1038/bjc.2015.61
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High circulating neutrophil-lymphocyte ratio (NLR) appears to be prognostic in metastatic colorectal cancer (mCRC). We investigated the relationship of NLR with circulating cytokines and molecular alterations. Methods: We performed retrospective analyses on multiple cohorts of CRC patients (metastatic untreated (n = 166), refractory metastatic (n = 161), hepatectomy (n = 198), stage 2/3 (n = 274), and molecularly screened (n = 342)). High NLR (ratio of absolute neutrophil-to-lymphocyte counts in peripheral blood) was defined as NLR>5. Plasma cytokines were evaluated using multiplex-bead assays. Kaplan-Meier estimates, non-parametric correlation analysis, and hierarchical cluster analyses were used. Results: High NLR was associated with poor prognosis in mCRC (hazard ratio (HR) 1.73; 95% confidence interval (CI): 1.03-2.89; P = 0.039) independent of known prognostic factors and molecular alterations (KRAS/NRAS/BRAF/PIK3CA/CIMP). High NLR correlated with increased expression of interleukin 6 (IL-6), IL-8, IL-2R alpha, hepatocyte growth factor, macrophage-colony stimulating factor, and vascular epidermal growth factor in exploratory (n = 39) and validation (n = 166) cohorts. Fourteen additional cytokines correlated with high NLR in the validation cohort. All 20 cytokines fell into three major clusters: inflammatory cytokines, angiogenic cytokines, and epidermal growth factor ligands. In mCRC, composite stratification based on NLR-cytokine score provided enhanced prognostic information (HR 2.09; 95% CI: 1.59-2.76; P<0.001) over and above NLR. Conclusions: High NLR is an independent poor prognostic marker in CRC and correlates with a distinct cytokine profile related to key biological processes involved in carcinogenesis. A composite NLR-cytokine stratification has enhanced prognostic value in mCRC.
引用
收藏
页码:1088 / 1097
页数:10
相关论文
共 48 条
[1]  
Absenger G, 2013, ANTICANCER RES, V33, P4591
[2]   Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis [J].
Bandapalli, Obul R. ;
Ehrmann, Franziska ;
Ehemann, Volker ;
Gaida, Matthias ;
Macher-Goeppinger, Stephan ;
Wente, Moritz ;
Schirmacher, Peter ;
Brand, Karsten .
CYTOKINE, 2012, 57 (01) :46-53
[3]   Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer [J].
Bisgin, Atil ;
Kargi, Aysegul ;
Yalcin, Arzu D. ;
Aydin, Cigdem ;
Ekinci, Deniz ;
Savas, Burhan ;
Sanlioglu, Salih .
BMC CANCER, 2012, 12
[4]   Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability [J].
Colotta, Francesco ;
Allavena, Paola ;
Sica, Antonio ;
Garlanda, Cecilia ;
Mantovani, Alberto .
CARCINOGENESIS, 2009, 30 (07) :1073-1081
[5]   Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? [J].
Coussens, Lisa M. ;
Zitvogel, Laurence ;
Palucka, A. Karolina .
SCIENCE, 2013, 339 (6117) :286-291
[6]   Cancer-related inflammation and treatment effectiveness [J].
Diakos, Connie I. ;
Charles, Kellie A. ;
McMillan, Donald C. ;
Clarke, Stephen J. .
LANCET ONCOLOGY, 2014, 15 (11) :E493-E503
[7]   ULCERATIVE-COLITIS AND COLORECTAL-CANCER - A POPULATION-BASED STUDY [J].
EKBOM, A ;
HELMICK, C ;
ZACK, M ;
ADAMI, HO .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (18) :1228-1233
[8]  
Emoto K, 2001, CANCER, V92, P1419, DOI 10.1002/1097-0142(20010915)92:6<1419::AID-CNCR1465>3.0.CO
[9]  
2-J
[10]   Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer [J].
Erreni, Marco ;
Mantovani, Alberto ;
Allavena, Paola .
CANCER MICROENVIRONMENT, 2011, 4 (02) :141-154